Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 847 of 1,261

  1. US 8563599

    Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof

    THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  2. US 8563731

    Mesylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]jamino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor

    Almirall, S.A. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  3. US 8563730

    Pyrazole and fused pyrazole glucokinase activators

    Takeda San Diego, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  4. US 8563651

    Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  5. US 8563692

    Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  6. US 8563618

    Skin external preparation having excellent stability

    KURARAY CO., LTD. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  7. US 8563575

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  8. US 8563569

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  9. US 8563515

    Tight junction protein modulators and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  10. US 8563503

    Antibiotic, its nucleotide sequence, methods of construction and uses thereof

    PROTEIN DESIGN LAB, LTD. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  11. US 8563314

    Methods and compositions for modulating PD1

    Sangamo Biosciences, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  12. US 8563039

    Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

    Anika Therapeutics S.r.l. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  13. US 8563035

    Oral tablet compositions of dexlansoprazole

    Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  14. US 8563034

    Dual release oral tablet compositions of dexlansoprazole

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  15. US 8563022

    Particles for cell targeting

    The Board of Regents of the University of Texas System · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  16. US 8563023

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  17. US 8563014

    Modafinil oral lyophilizate

    Teva Sante · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  18. US 8563001

    Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease

    Regents of the University of Minnesota · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  19. DE 102012007671

    Pellets mit hohem Wirkstoffgehalt

    ACINO PHARMA AG [CH] · Granted Oct 17, 2013 · Expires Oct 12, 2033

    granted

  20. US 8557764

    Methods of modulating immune function

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  21. US 8557800

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  22. US 8557818

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  23. US 8557978

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  24. US 8557806

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.